Crinetics Pharmaceuticals, Inc. - 10-Q Filing
Crinetics Pharmaceuticals filed its quarterly report on Form 10-Q for the period ended March 31, 2026. The filing provides financial and operational updates including revenue from product sales and license agreements, research and development expenses, general administrative costs, and details about stock-based compensation programs.
Tickers: $CRNX